Version 2.79

Term Description

This subsection, which is contained in the Adverse Reactions section, describes the product's potential ability to trigger an immune response, according to the Physical Labeling Rule format. [https://www.fda.gov/OHRMS/DOCKETS/98fr/06-545.pdf]

Fully-Specified Name

Component
Immunogenicity
Property
-
Time
-
System
^FDA package insert
Scale
Nar
Method

Additional Names

Long Common Name
FDA package insert Immunogenicity
Short Name
FDA insert Immunogenicity

Basic Attributes

Class
DOC.REF
Type
Clinical
First Released
Version 2.64
Last Updated
Version 2.64 (ADD)
Order vs. Observation
Both

Language Variants Get Info

Tag Language Translation
el-GR Greek (Greece) Ανοσογονικότητα:-:-:^Ένθετο συσκευασίας FDA:Nar:
Synonyms: Ανοσογονικότητα
es-MX Spanish (Mexico) Inmunogenicidad:-:-:^ Prospecto de la FDA:Narrativo:
it-IT Italian (Italy) Immunogenicità:-:-:^FDA, foglio illustrativo:Nar:
Synonyms: Documentazione di riferimento Foglio illustrativo della Food and Drug Administra
zh-CN Chinese (China) 免疫原性:-:-:^FDA 包装说明书:叙述型:
Synonyms: SPL;结构化产品标签;结构化产品标签;Structured Product Labelling;结构化产品标记;结构化产品标识;美国食品及药品管理局包装说明书;超系统 - FDA 包装说明书;食品及药品管理局包装说明书;FDA 包装插页 免疫生成性;抗原性;免疫抗原性 参考文件;参考文档;引用文件;引用文档;文件.参考;文件.引用;文档.引用 叙述;叙述性文字;报告;报告型;文字叙述;文本叙述型;文本描述;文本描述型

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=88830-5